Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-344987
Filing Date
2026-08-11
Accepted
2026-08-11 17:09:37
Documents
61
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001774857-20260630.htm   iXBRL 10-Q 2488970
2 EX-10.1 ck0001774857-ex10_1.htm EX-10.1 32965
3 EX-10.2 ck0001774857-ex10_2.htm EX-10.2 33833
4 EX-31.1 ck0001774857-ex31_1.htm EX-31.1 18854
5 EX-31.2 ck0001774857-ex31_2.htm EX-31.2 18831
6 EX-32.1 ck0001774857-ex32_1.htm EX-32.1 12688
7 EX-32.2 ck0001774857-ex32_2.htm EX-32.2 12445
8 GRAPHIC img26816789_0.gif GRAPHIC 4990
9 GRAPHIC img26816789_1.gif GRAPHIC 4990
10 GRAPHIC img27740310_0.gif GRAPHIC 4990
11 GRAPHIC img27740310_1.gif GRAPHIC 4990
  Complete submission text file 0001193125-26-344987.txt   7248415

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001774857-20260630.xsd EX-101.SCH 787279
65 EXTRACTED XBRL INSTANCE DOCUMENT ck0001774857-20260630_htm.xml XML 938555
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Filer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42513 | Film No.: 261264327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)